Kuros Biosciences AG / Key word(s): Study Kuros Biosciences completes enrolment in Level 1 clinical study of MagnetOs Granules 02.11.2022 / 07:00 CET/CEST Preliminary data shows 78%
26.10.2022 - Kuros Biosciences AG / Key word(s): Miscellaneous Kuros reports 73% increase in MagnetOs sales in first nine months of 2022 26-Oct-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for . Seite 1
Kuros Biosciences AG / Key word(s): Miscellaneous Kuros reports 73% increase in MagnetOs sales in first nine months of 2022 26-Oct-2022 / 07:00 CET/CEST Release of an ad hoc announcement pursuant
Kuros Biosciences AG / Key word(s): Miscellaneous Kuros Biosciences to present positive clinical data for MagnetOs at NASS 2022 Annual Meeting 11.10.2022 / 07:00 CET/CEST First clinical